List of stem cell stocks

Here’s a great list of companies specializing in stem cell research. The list was originally published here. Some of the companies on the original list are no longer around.

The list below is more accurate than the original.

Aastrom Biosciences Inc. (Nasdaq: ASTM)
Develops patient-specific products for the repair or regeneration of human tissues, using proprietary adult stem cell technology.

AVI Biopharma (Nasdaq: AVII)
A biopharmaceutical company developing drugs to treat life-threatening diseases using third-generation antisense technology.

BrainStorm Cell (Nasdaq: BCLI)
Developer of stem cell therapeutic products based on breakthrough technologies, including their core technology, NurOwn™.

Cord Blood America Inc. (OTCBB: CBAI)
Provides collection, testing, processing, and preservation services of the blood of umbilical cords.

CRYO-CELL (Nasdaq: CCEL)
The world’s oldest & largest family cord blood stem cell bank, for expectant parents for the private collection, processing & cryopreservation of their newborn’s non-controversial U-Cord® stem cells.

Cytori Therapeutics (Frankfurt: XMPA)
Develops proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat, and developed developed its proprietary Celution(TM) System to isolate and concentrate a patient’s own stem and regenerative cells in about an hour.
Geron (Nasdaq: GERN) Develops therapeutic products for oncology that target telomerase; pharmaceuticals that activate telomerase in tissues impacted by senescence, injury or degenerative disease; and cell-based therapies derived from its human embryonic stem cell platform for applications in multiple chronic diseases.
MultiCell (OTCBB: MCET)
Developer of therapeutic products, an adult stem cell company and a supplier of immortalized human cell lines for drug discovery applications.

Stem Cell Thera (TSX.V: SSS)
A biotechnology company focused on the development of its technology platform and intellectual property to selectively induce a patient’s own stem cells to proliferate in the brain.

Stem Cells (Nasdaq: STEM)
Developer of stem cell therapeutics to treat damage to or degeneration of major organ systems such as the central nervous system, liver and pancreas.

ThermoGenesis (Nasdaq: KOOL)
Provides Healthcare professionals with the means to micro-manufacture potentially life-saving and life-enhancing products from individual units of blood.

This entry was posted on Monday, March 9th, 2009 at 7:04 pm by admin and is filed under Health Care Stocks, Technology Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.